FINWIRES · TerminalLIVE
FINWIRES

Top Midday Stories: GE Vernova Shares Gain on Strong Q1 Earnings, Guidance; Vertiv Lifts Guidance After Q1 EPS, Revenue Beats, Shares Fall

-- All three major US stock indexes were up in late-morning trading Wednesday following reports of Iranian attacks on vessels in the Strait of Hormuz and President Donald Trump's extension of the ceasefire between the warring nations.

In company news, GE Vernova (GEV) reported Q1 earnings Wednesday of $17.44 per share, up from $0.91 a year earlier. Total Q1 revenue was $9.34 billion, up from $8.03 billion a year ago and above the FactSet consensus analyst estimate of $9.25 billion. For 2026, the company said it expects revenue of about $44.5 billion to $45.5 billion, up from its previous outlook of $44 billion to $45 billion and compared to the FactSet consensus of $44.66 billion. GE Vernova shares were up 12.4% around midday.

Vertiv (VRT) reported Q1 adjusted earnings Wednesday of $1.17 per diluted share, up from $0.64 a year earlier and above the FactSet consensus of $1.00. First-quarter revenue was $2.65 billion, up from $2.04 billion a year ago and above the FactSet consensus of $2.64 billion. For Q2, the company said it expects adjusted EPS of $1.37 to $1.43 on revenue of $3.25 billion to $3.45 billion. Analysts polled by FactSet expect $1.43 and $3.40 billion, respectively. For full-year 2026, Vertiv said it expects adjusted EPS of $6.30 to $6.40, up from its previous outlook of $5.97 to $6.07 and above the FactSet consensus of $6.12. Vertiv expects full-year revenue to be $13.50 billion to $14.00 billion, up from its previous guidance of $13.25 billion to $13.75 billion and compared to the FactSet consensus of $13.63 billion. Vertiv shares were down 2.6%.

Merck (MRK), Germany's Merck KGaA and Japan's Ono Pharmaceutical have expressed interest in Inhibrx Biosciences' (INBX) experimental cancer medicine that could be valued at over $8 billion, Reuters reported Wednesday, citing people familiar with the matter. Merck shares were down 0.2%, while Inhibrx shares were up 31.9%.

Boeing (BA) reported a Q1 core loss Wednesday of $0.20 per share, narrowing from a loss of $0.49 a year earlier and compared to the FactSet consensus estimate of a loss of $0.68. First-quarter revenue was $22.22 billion, up from $19.50 billion a year ago and above the FactSet consensus of $21.85 billion. Cash outflow for the quarter was $1.45 billion, narrowing from $2.29 billion a year ago, and the company said Q1 deliveries increased 10% to 143 planes. Boeing shares were up 5.4%.

Alphabet's (GOOG, GOOGL) Google Cloud is launching a $750 million fund to help consulting firms like Accenture (ACN), McKinsey and Deloitte get their clients to use agentic AI software, Bloomberg reported Wednesday, citing an emailed statement and an interview with a company official. Alphabet's Class C and Class A shares were up 1.5% and 1.6%, respectively. Accenture shares were down 1.9%.

Philip Morris International (PM) reported Q1 adjusted earnings Wednesday of $1.96 per diluted share, up from $1.69 a year earlier and above the FactSet consensus of $1.83. Net Q1 revenue was $10.15 billion, up from $9.30 billion ay ear ago and above the FactSet consensus of $9.91 billion. For Q2, Philip Morris said it expects adjusted EPS of $2.02 to $2.07, below the FactSet consensus of $2.12. For full-year 2026, the company said it expects adjusted EPS of $8.36 to $8.51, compared to the FactSet consensus of $8.38. Philip Morris shares were up 7%.

Boston Scientific (BSX) reported Q1 adjusted earnings Wednesday of $0.80 per share, up from $0.75 a year earlier and above the FactSet consensus of $0.79. First-quarter net sales were $5.20 billion, up from $4.66 billion a year ago and above the FactSet consensus of $5.17 billion. For Q2, Boston Scientific said it expects adjusted EPS of $0.82 to $0.84 and net sales growth of 5.5% to 7.5%. Analysts polled by FactSet expect adjusted EPS of $0.86. For full-year 2026, the company said it expects adjusted EPS of $3.34 to $3.41, down from its prior outlook of $3.43 to $3.49 and below the FactSet consensus of $3.45. Full-year net sales are now expected to grow about 7.0% to 8.5%, down from the company's previous guidance of 10.5% to 11.5% growth. Shares of the company were up 8.4%.

AT&T (T) reported Q1 earnings Wednesday of $0.54 per diluted share, down from $0.61 a year earlier and below the FactSet consensus of $0.55. First-quarter operating revenue was $31.51 billion, up from $30.63 billion a year ago and above the FactSet consensus of $31.25 billion. AT&T shares were down 1.8%.

Price: $1119.35, Change: $+128.05, Percent Change: +12.92%

Related Articles

Asia

Market Chatter: SMFG Targets to Manage 10 Trillion Yen in University Assets

Sumitomo Mitsui Financial Group (TYO:8316) or SMFG plans to launch a full-scale asset management service for Japanese universities as investment becomes more crucial for higher education, Nikkei Asia reported on Friday.Private universities and junior colleges hold an estimated 10 trillion yen or $62.7 billion in assets - mainly in cash equivalents and bonds, the news daily said, citing the Promotion and Mutual Aid Corporation for Private Schools of Japan (PMAC).While Japan's national universities have become more proactive with their assets, directing more money toward growth-oriented investments, their exposure to stocks and investment trusts remains limited, the report said.(Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)

$TYO:8316
Asia

FireFly Metals Secures Approvals to Divest Canada Project to Bellavista Resources

FireFly Metals (ASX:FFM) and Bellavista Resources (ASX:BVR) obtained all necessary shareholder approvals and satisfied or waived remaining conditions for the sale of FireFly's Ontario gold portfolio, including its 70% stake in the Pickle Crow Project and full ownership of the Sioux Lookout Project, according to a Friday filing with the Australian bourse.Completion of the transaction is expected on April 29, per the filing.Firefly will receive 60 million Bellavista shares upfront, along with 50 million performance rights, with an in-specie distribution to shareholders scheduled for May 11, equating to around one Bellavista share for every 12.8 Firefly shares held, the filing said.The transaction includes a waiver of the Australian Taxation Office class ruling condition, with tax treatment still pending final confirmation, the filing added.FireFly Metals and Bellavista Resources' shares each shed about 1% in recent Friday trade.

$ASX:BVR$ASX:FFM
Research

Research Alert: CFRA Reiterates Buy Opinion On Shares Of Pool Corporation

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We raise our 12-month price target by $17 to $269, based on 24x our 2026 EPS estimate (up from 23x), a discount to POOL's 26x five-year average forward multiple, reflecting cyclical headwinds to new pool construction. We raise our 2026 EPS estimate to $11.20 from $10.95 and raise 2027's to $11.94 from $11.81, reflecting strong Q1 chemical (+8% Y/Y), equipment (+7% Y/Y) sales growth and gradual improvement in building materials growth (+5% Y/Y). We reiterate our Buy opinion, viewing management's 2026 EPS guidance of $10.87-$11.17 as achievable given low single-digit sales growth and flat operating margins, with upside as tariff cost impacts wane. We think POOL's unmatched scale (455 sales centers) provides it key advantages, including a differentiated product portfolio, ability to ramp private label product sales, and technology (POOL360) and supplier partnerships that support the company's ability to gain market share of the 5.5 million installed pool base in the U.S.

$POOL